Laurus Labs Limited (BOM:540222)
1,361.60
-19.55 (-1.42%)
At close: May 29, 2026
Laurus Labs Revenue
In the fiscal year ending March 31, 2026, Laurus Labs had annual revenue of 68.13B INR with 22.67% growth. Laurus Labs had revenue of 18.12B in the quarter ending March 31, 2026, with 5.31% growth.
Revenue
68.13B
Revenue Growth
+22.67%
P/S Ratio
10.79
Revenue / Employee
11.05M
Employees
6,167
Market Cap
735.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 68.13B | 12.59B | 22.67% |
| Mar 31, 2025 | 55.54B | 5.13B | 10.18% |
| Mar 31, 2024 | 50.41B | -10.00B | -16.55% |
| Mar 31, 2023 | 60.41B | 11.05B | 22.39% |
| Mar 31, 2022 | 49.36B | 1.22B | 2.54% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 23.19B |
| Neuland Laboratories | 20.23B |
| Shilpa Medicare | 15.49B |
| Bajaj HealthCare | 6.11B |
| NGL Fine-Chem | 5.01B |
| Sai Parenteral's | 3.90B |
| Anlon Healthcare | 1.70B |
| Gujarat Themis Biosyn | 1.68B |
Laurus Labs News
- 9 days ago - Laurus Labs included in Dow Jones Best-in-Class indices for ESG performance - Business Upturn
- 4 weeks ago - Laurus Labs Transcript: Q4 25/26 - Transcripts
- 4 weeks ago - Laurus Labs Quarterly report: Q4 2026 - Filings
- 4 weeks ago - Laurus Labs Slides: Q4 2026 - Filings
- 4 weeks ago - Laurus Labs announces voluntary closure of Laurus Generics GmbH - Business Upturn
- 4 weeks ago - Laurus Labs approves €9.8 million investment in KRKA Pharma joint venture - Business Upturn
- 4 weeks ago - Laurus Labs reports ₹6,813 crore revenue for FY26 with 23% growth - Business Upturn
- 4 weeks ago - Laurus Labs Q4 Results: Profit rises 19% YoY as margin expands nearly 400 bps - Business Upturn